Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

Avandia

Avandia probe deepens

June 29, 2010
Sales and Marketing Avandia, GlaxoSmithKline, diabetes

GlaxoSmithKline has come under further scrutiny from the FDA after two new studies showed patients taking its troubled diabetes medication …

News

Boehringer cheered by diabetes data

June 28, 2010
Research and Development Boehringer, DPP-4, diabetes, linagliptin

Boehringer Ingelheim has been cheered by phase III data showing its new oral once-daily type II diabetes tablet linagliptin significantly …

News

Sanofi licences novel oral anti-diabetic treatment

June 25, 2010
Research and Development, Sales and Marketing Metabolex, Sanofi-Aventis, diabetes

Sanofi-Aventis has signed an exclusive worldwide licensing agreement with US-based diabetes specialist Metabolex for a novel oral anti-diabetic treatment. MBX-2982 …

News
Blog footer

Digital Pharma: Playing healthcare games

June 23, 2010
Medical Communications Boehringer, Novartis, diabetes, digi game, malaria, virtual games

Boehringer Ingelheim has become the latest pharma company to use an online game to raise disease awareness. The pharma company …

News
Victoza pack

Victoza wins partial NICE recommendation

June 15, 2010
Sales and Marketing NICE, Victoza, diabetes

Novo Nordisk has been given a limited approval for its new type II diabetes treatment in draft guidance issued by …

News

Lixisenatide scores in phase III trial

April 15, 2010
Research and Development GLP-1, Lixisenatide, diabetes

Sanofi-Aventis’ novel, once-daily diabetes treatment lixisenatide has successfully met its phase III glucose blood level and glycaemic control endpoints. The …

News

Roche buys insulin patch company

April 13, 2010
Research and Development Diagnostics, Roche, diabetes

Roche has acquired insulin delivery specialist company Medingo to consolidate its presence in the diabetes care market.  Medingo, formerly a …

News

Sanofi-Aventis signs drug with potential to reverse diabetes

April 9, 2010
Research and Development Sanofi, diabetes

Sanofi-Aventis has signed a deal with a US biotech firm to develop a new treatment which could restore patients’ ability …

News

Five-year cardiovascular study planned for Onglyza

March 10, 2010
Research and Development, Sales and Marketing DPP-4, Onglyza, diabetes

Bristol-Myers Squibb and AstraZeneca are to embark on a five-year study of Onglyza in type II diabetes patients who may …

News

Stem cell therapy helps diabetes limb problems

March 3, 2010
Research and Development ReNeuron, diabetes, stem cell

Stem cell therapy aimed at restoring blood flow to damaged limbs in people with diabetes has shown promise, according to UK …

News

GSK hits back at Avandia safety probe

February 25, 2010
Sales and Marketing Avandia, diabetes

GlaxoSmithKline has hit back at allegations from US Senators that its diabetes drug Avandia raises the risk of heart attacks, …

News
Avandia

Reports raise fresh Avandia safety questions

February 23, 2010
Research and Development, Sales and Marketing Avandia, GlaxoSmithKline, diabetes

GlaxoSmithKline’s troubled diabetes drug Avandia has been hit by fresh reports from the US that it increases the risk of …

News

Roche diabetes trial proves promising

February 11, 2010
Research and Development GLP-1, Roche, diabetes, taspoglutide

Phase III results for Roche’s once-weekly injectable drug taspoglutide have shown a positive effect on reducing blood glucose compared with …

News
Lilly laboratory

Lilly signs diabetes deal with Alizé Pharma

February 2, 2010
Research and Development Alize, diabetes, lilly, type II

Lilly has signed a new research and licensing deal with Lyon-based Alizé Pharma to develop Alizé’s AZP-01 programme, focused on …

News
Blog footer

Digital Pharma: Glucose monitoring for the Nintendo generation

January 20, 2010
Medical Communications Bayer, diabetes, digi, digi game, digital pharma

The Nintendo DS that arrived in our house on Christmas has already become my eldest son’s most favourite present of …

Feature
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026